Search Results 811-820 of 16049 for pharmacogenetics
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study includes collection of blood samples from the healthy controls and those with suspected bloodstream infections. Participation eligibility.
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
About this study. The purpose of this study is to establish a biobank of samples (blood and stool) to support the development of non-invasive tests for ...
The purpose of this study is to facilitate quality improvement and description of treatment with this novel dialysis device dedicated to the treatment of ...
... pharmacogenetics. Contemp Clin Trials. 2012 May; 33 (3):523-33 Epub 2012 Feb 10. View PubMed; Ratuapli SK, Ellington TG, O'Neill MT, Umar SB, Harris LA, Foxx ...
The purpose of this study is to develop a cohort (biobank of biospecimens and data) of subjects without pancreatic cancer who are at high-risk for pancreatic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.